Literature DB >> 21898098

Hypoxemia correlates with attentional dysfunction in patients with obstructive sleep apnea.

Isaac Shpirer1, Arnon Elizur, Ran Shorer, Ruth Bernstein Peretz, Jose M Rabey, Michael Khaigrekht.   

Abstract

PURPOSE: Obstructive sleep apnea is associated with cognitive impairment, but whether hypoxemia or repeated arousals and sleepiness are the underlying mechanism is controversial. Studies using a wide range of attention and executive functions tests in patients with severe sleep apnea are lacking.
METHODS: In a prospective cohort study, 40 patients aged 30-70 years, diagnosed with obstructive sleep apnea (apnea-hypopnea index ≥5) were recruited. Patients with known cardiovascular, pulmonary, psychiatric, or neurological disease, and or patients receiving anti-psychotic, sedatives, or stimulant medications were excluded. Patients underwent full overnight polysomnography including continuous oxygen saturation measurements followed by extensive neuropsychological testings in attention and executive function domains. The correlation between sleep apnea severity and patients' performance on the neuropsychological tests was examined.
RESULTS: The patients' performance on measures of attention and executive function was significantly worse compared to the average in a normal population. Attention, as reflected by the number of omissions and by the reaction time on the Conners' Continuous Performance Test correlated significantly with the apnea-hypopnea index (r = 0.6, p < 0.001 and r = 0.48, p = 0.003, respectively) and with parameters of hypoxemia, namely the average SpO(2) (r = -0.51, p = 0.002 and r = -0.39, p = 0.02, respectively) and the percent time spent with SpO(2) < 90% (r = 0.57, p < 0.001 and r = 0.39, p = 0.02, respectively), but not with the degree of sleepiness. Executive dysfunction did not correlate with sleep parameters. DISCUSSION: Attention is the predominant cognitive function affected in patients with obstructive sleep apnea and correlates primarily with nocturnal hypoxemia rather than daytime sleepiness or sleep fragmentation. Executive functions, while below average in some patients, do not correlate with polysomnographic parameters.

Entities:  

Mesh:

Year:  2011        PMID: 21898098     DOI: 10.1007/s11325-011-0582-1

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  21 in total

1.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

2.  Relation of measures of sleep-disordered breathing to neuropsychological functioning.

Authors:  N Adams; M Strauss; M Schluchter; S Redline
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

3.  The association between obstructive sleep apnea and neurocognitive performance--the Apnea Positive Pressure Long-term Efficacy Study (APPLES).

Authors:  Stuart F Quan; Cynthia S Chan; William C Dement; Alan Gevins; James L Goodwin; Daniel J Gottlieb; Sylvan Green; Christian Guilleminault; Max Hirshkowitz; Pamela R Hyde; Gary G Kay; Eileen B Leary; Deborah A Nichols; Paula K Schweitzer; Richard D Simon; James K Walsh; Clete A Kushida
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

4.  Sleep-disordered breathing and neuropsychological deficits. A population-based study.

Authors:  H C Kim; T Young; C G Matthews; S M Weber; A R Woodward; M Palta
Journal:  Am J Respir Crit Care Med       Date:  1997-12       Impact factor: 21.405

Review 5.  Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery.

Authors:  A Décary; I Rouleau; J Montplaisir
Journal:  Sleep       Date:  2000-05-01       Impact factor: 5.849

6.  Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia.

Authors:  L J Findley; J T Barth; D C Powers; S C Wilhoit; D G Boyd; P M Suratt
Journal:  Chest       Date:  1986-11       Impact factor: 9.410

7.  Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits.

Authors:  M A Bédard; J Montplaisir; F Richer; I Rouleau; J Malo
Journal:  J Clin Exp Neuropsychol       Date:  1991-11       Impact factor: 2.475

8.  Executive function in sleep apnea: controlling for attentional capacity in assessing executive attention.

Authors:  Edwin Verstraeten; Raymond Cluydts; Dirk Pevernagie; Guy Hoffmann
Journal:  Sleep       Date:  2004-06-15       Impact factor: 5.849

9.  Deficits of cognitive executive functions in patients with sleep apnea syndrome.

Authors:  B Naëgelé; V Thouvard; J L Pépin; P Lévy; C Bonnet; J E Perret; J Pellat; C Feuerstein
Journal:  Sleep       Date:  1995-01       Impact factor: 5.849

10.  Executive dysfunction in patients with obstructive sleep apnea syndrome.

Authors:  Tiia Saunamäki; Sari-Leena Himanen; Olli Polo; Mervi Jehkonen
Journal:  Eur Neurol       Date:  2009-08-06       Impact factor: 1.710

View more
  21 in total

Review 1.  Cognitive impairment in obstructive sleep apnea syndrome: a descriptive review.

Authors:  Mina Caporale; Rosanna Palmeri; Francesco Corallo; Nunzio Muscarà; Laura Romeo; Alessia Bramanti; Silvia Marino; Viviana Lo Buono
Journal:  Sleep Breath       Date:  2020-05-23       Impact factor: 2.816

2.  Vitamin D Improves Selected Metabolic Parameters but Not Neuropsychological or Quality of Life Indices in OSA: A Pilot Study.

Authors:  Conor P Kerley; Katrina Hutchinson; Jessica Bramham; Aisling McGowan; John Faul; Liam Cormican
Journal:  J Clin Sleep Med       Date:  2017-01-15       Impact factor: 4.062

3.  Impaired hypoxic cerebral vasodilation in younger adults with metabolic syndrome.

Authors:  John W Harrell; Barbara J Morgan; William G Schrage
Journal:  Diab Vasc Dis Res       Date:  2012-07-02       Impact factor: 3.291

4.  Levels of neuroglobin in serum and neurocognitive impairments in Chinese patients with obstructive sleep apnea.

Authors:  Min Xu; Ying Yang; Junjian Zhang
Journal:  Sleep Breath       Date:  2012-06-07       Impact factor: 2.816

5.  Sleep breathing disorders and cognitive function in the elderly: an 8-year follow-up study. the proof-synapse cohort.

Authors:  Magali Saint Martin; Emilia Sforza; Frédéric Roche; Jean Claude Barthélémy; Catherine Thomas-Anterion
Journal:  Sleep       Date:  2015-02-01       Impact factor: 5.849

Review 6.  Clinical Presentation, Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Older Adults: A Review of the Evidence and its Implications for Clinical Care.

Authors:  David W Goodman; Sara Mitchell; Lauren Rhodewalt; Craig B H Surman
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

7.  Effect of CPAP therapy on C-reactive protein and cognitive impairment in patients with obstructive sleep apnea hypopnea syndrome.

Authors:  Shu Qing Wu; Qing Chi Liao; Xing Xiang Xu; Li Sun; Jing Wang; Rui Chen
Journal:  Sleep Breath       Date:  2016-03-18       Impact factor: 2.816

8.  Obstructive sleep apnea, cognition and Alzheimer's disease: A systematic review integrating three decades of multidisciplinary research.

Authors:  Omonigho M Bubu; Andreia G Andrade; Ogie Q Umasabor-Bubu; Megan M Hogan; Arlener D Turner; Mony J de Leon; Gbenga Ogedegbe; Indu Ayappa; Girardin Jean-Louis G; Melinda L Jackson; Andrew W Varga; Ricardo S Osorio
Journal:  Sleep Med Rev       Date:  2019-12-12       Impact factor: 11.609

Review 9.  Cognition in obstructive sleep apnea-hypopnea syndrome (OSAS): current clinical knowledge and the impact of treatment.

Authors:  Stephanie A Kielb; Sonia Ancoli-Israel; George W Rebok; Adam P Spira
Journal:  Neuromolecular Med       Date:  2012-05-09       Impact factor: 3.843

Review 10.  Effect of obstructive sleep apnea on type 2 diabetes mellitus: A comprehensive literature review.

Authors:  Srikant Nannapaneni; Kannan Ramar; Salim Surani
Journal:  World J Diabetes       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.